405 related articles for article (PubMed ID: 26884348)
1. Tripartite motif 32 prevents pathological cardiac hypertrophy.
Chen L; Huang J; Ji Y; Zhang X; Wang P; Deng K; Jiang X; Ma G; Li H
Clin Sci (Lond); 2016 May; 130(10):813-28. PubMed ID: 26884348
[TBL] [Abstract][Full Text] [Related]
2. TRIM24 protein promotes and TRIM32 protein inhibits cardiomyocyte hypertrophy via regulation of dysbindin protein levels.
Borlepawar A; Rangrez AY; Bernt A; Christen L; Sossalla S; Frank D; Frey N
J Biol Chem; 2017 Jun; 292(24):10180-10196. PubMed ID: 28465353
[TBL] [Abstract][Full Text] [Related]
3. Caspase recruitment domain 6 protects against cardiac hypertrophy in response to pressure overload.
Li L; Chen W; Zhu Y; Wang X; Jiang DS; Huang F; Wang L; Xiang F; Qin W; Wang Q; Zhang R; Zhu X; Li H; Chen X
Hypertension; 2014 Jul; 64(1):94-102. PubMed ID: 24777975
[TBL] [Abstract][Full Text] [Related]
4. Tripartite Motif 8 Contributes to Pathological Cardiac Hypertrophy Through Enhancing Transforming Growth Factor β-Activated Kinase 1-Dependent Signaling Pathways.
Chen L; Huang J; Ji YX; Mei F; Wang PX; Deng KQ; Jiang X; Ma G; Li H
Hypertension; 2017 Feb; 69(2):249-258. PubMed ID: 27956576
[TBL] [Abstract][Full Text] [Related]
5. Analysis of the Zn-Binding Domains of TRIM32, the E3 Ubiquitin Ligase Mutated in Limb Girdle Muscular Dystrophy 2H.
Lazzari E; El-Halawany MS; De March M; Valentino F; Cantatore F; Migliore C; Onesti S; Meroni G
Cells; 2019 Mar; 8(3):. PubMed ID: 30884854
[TBL] [Abstract][Full Text] [Related]
6. Tripartite motif 10 regulates cardiac hypertrophy by targeting the PTEN/AKT pathway.
Yang H; Wang XX; Zhou CY; Xiao X; Tian C; Li HH; Yin CL; Wang HX
J Cell Mol Med; 2020 Jun; 24(11):6233-6241. PubMed ID: 32343488
[TBL] [Abstract][Full Text] [Related]
7. Restoration of Circulating MFGE8 (Milk Fat Globule-EGF Factor 8) Attenuates Cardiac Hypertrophy Through Inhibition of Akt Pathway.
Deng KQ; Li J; She ZG; Gong J; Cheng WL; Gong FH; Zhu XY; Zhang Y; Wang Z; Li H
Hypertension; 2017 Oct; 70(4):770-779. PubMed ID: 28827473
[TBL] [Abstract][Full Text] [Related]
8. Toll-interacting protein (Tollip) negatively regulates pressure overload-induced ventricular hypertrophy in mice.
Liu Y; Jiang XL; Liu Y; Jiang DS; Zhang Y; Zhang R; Chen Y; Yang Q; Zhang XD; Fan GC; Li H
Cardiovasc Res; 2014 Jan; 101(1):87-96. PubMed ID: 24285748
[TBL] [Abstract][Full Text] [Related]
9. Novel role for caspase-activated DNase in the regulation of pathological cardiac hypertrophy.
Gao L; Huang K; Jiang DS; Liu X; Huang D; Li H; Zhang XD; Huang K
Hypertension; 2015 Apr; 65(4):871-81. PubMed ID: 25646292
[TBL] [Abstract][Full Text] [Related]
10. The E3 Ligase TRIM16 Is a Key Suppressor of Pathological Cardiac Hypertrophy.
Liu J; Li W; Deng KQ; Tian S; Liu H; Shi H; Fang Q; Liu Z; Chen Z; Tian T; Gan S; Hu F; Hu M; Cheng X; Ji YX; Zhang P; She ZG; Zhang XJ; Chen S; Cai J; Li H
Circ Res; 2022 May; 130(10):1586-1600. PubMed ID: 35437018
[TBL] [Abstract][Full Text] [Related]
11. Ubiquitin-specific protease 19 blunts pathological cardiac hypertrophy via inhibition of the TAK1-dependent pathway.
Miao R; Lu Y; He X; Liu X; Chen Z; Wang J
J Cell Mol Med; 2020 Sep; 24(18):10946-10957. PubMed ID: 32798288
[TBL] [Abstract][Full Text] [Related]
12. Targeting E3 Ubiquitin Ligase WWP1 Prevents Cardiac Hypertrophy Through Destabilizing DVL2 via Inhibition of K27-Linked Ubiquitination.
Zhao D; Zhong G; Li J; Pan J; Zhao Y; Song H; Sun W; Jin X; Li Y; Du R; Nie J; Liu T; Zheng J; Jia Y; Liu Z; Liu W; Yuan X; Liu Z; Song J; Kan G; Li Y; Liu C; Gao X; Xing W; Chang YZ; Li Y; Ling S
Circulation; 2021 Aug; 144(9):694-711. PubMed ID: 34139860
[TBL] [Abstract][Full Text] [Related]
13. TRIM32, but not its muscular dystrophy-associated mutant, positively regulates and is targeted to autophagic degradation by p62/SQSTM1.
Overå KS; Garcia-Garcia J; Bhujabal Z; Jain A; Øvervatn A; Larsen KB; Deretic V; Johansen T; Lamark T; Sjøttem E
J Cell Sci; 2019 Dec; 132(23):. PubMed ID: 31685529
[TBL] [Abstract][Full Text] [Related]
14. TRIM32 Promotes the Growth of Gastric Cancer Cells through Enhancing AKT Activity and Glucose Transportation.
Wang J; Fang Y; Liu T
Biomed Res Int; 2020; 2020():4027627. PubMed ID: 32051827
[TBL] [Abstract][Full Text] [Related]
15. TRIM32 promotes inflammatory responses in rheumatoid arthritis fibroblast-like synoviocytes.
Liang T; Song M; Xu K; Guo C; Xu H; Zhang H; Xu L
Scand J Immunol; 2020 Jun; 91(6):e12876. PubMed ID: 32145086
[TBL] [Abstract][Full Text] [Related]
16. RNF207 exacerbates pathological cardiac hypertrophy via post-translational modification of TAB1.
Yuan L; Bu S; Du M; Wang Y; Ju C; Huang D; Xu W; Tan X; Liang M; Deng S; Yang L; Huang K
Cardiovasc Res; 2023 Mar; 119(1):183-194. PubMed ID: 35352799
[TBL] [Abstract][Full Text] [Related]
17. Tripartite motif‑containing 14 may aggravate cardiac hypertrophy via the AKT signalling pathway in neonatal rat cardiomyocytes and transgenic mice.
Hou H; Chen Y; Feng X; Xu G; Yan M
Mol Med Rep; 2023 Sep; 28(3):. PubMed ID: 37503784
[TBL] [Abstract][Full Text] [Related]
18. Novel Protective Role for Ubiquitin-Specific Protease 18 in Pathological Cardiac Remodeling.
Ying X; Zhao Y; Yao T; Yuan A; Xu L; Gao L; Ding S; Ding H; Pu J; He B
Hypertension; 2016 Nov; 68(5):1160-1170. PubMed ID: 27572150
[TBL] [Abstract][Full Text] [Related]
19. RING protein Trim32 associated with skin carcinogenesis has anti-apoptotic and E3-ubiquitin ligase properties.
Horn EJ; Albor A; Liu Y; El-Hizawi S; Vanderbeek GE; Babcock M; Bowden GT; Hennings H; Lozano G; Weinberg WC; Kulesz-Martin M
Carcinogenesis; 2004 Feb; 25(2):157-67. PubMed ID: 14578165
[TBL] [Abstract][Full Text] [Related]
20. The interaction of Piasy with Trim32, an E3-ubiquitin ligase mutated in limb-girdle muscular dystrophy type 2H, promotes Piasy degradation and regulates UVB-induced keratinocyte apoptosis through NFkappaB.
Albor A; El-Hizawi S; Horn EJ; Laederich M; Frosk P; Wrogemann K; Kulesz-Martin M
J Biol Chem; 2006 Sep; 281(35):25850-66. PubMed ID: 16816390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
